High-dose chemotherapy for relapsed testicular germ cell tumours

Nature Reviews Urology, Published online: 07 December 2022; doi:10.1038/s41585-022-00683-1This Review summarizes current knowledge regarding salvage high-dose chemotherapy in relapsed germ cell tumours. The authors outline data from phase I and II clinical trials, phase III randomized trials and retrospective datasets, discuss controversies and provide recommendations.

Source: Nature Reviews Urology - December 7, 2022 Category: Urology & Nephrology Authors: Michal Chovanec Nabil Adra Mohammad Abu Zaid Rafat Abonour Lawrence Einhorn Source Type: research